Shaoyi Li

1.7k total citations
15 papers, 509 citations indexed

About

Shaoyi Li is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shaoyi Li has authored 15 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Shaoyi Li's work include Ginseng Biological Effects and Applications (2 papers), MicroRNA in disease regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). Shaoyi Li is often cited by papers focused on Ginseng Biological Effects and Applications (2 papers), MicroRNA in disease regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). Shaoyi Li collaborates with scholars based in China, United States and Spain. Shaoyi Li's co-authors include Yun Gao, Yunhui Liu, Wenchang Guo, Markus F. Renschler, Martin Reck, José Trigo, Kristiaan Nackaerts, Jeffrey A. Bubis, J. Mezger and Philip Clingan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Shaoyi Li

13 papers receiving 501 citations

Peers

Shaoyi Li

ONCOL

EPIDE

PRM

Rong Chu United States

Yeo Wool Kang South Korea

Lu Zhao China

Nobuyuki Takaoka Japan

Vasudha Sehgal United States

Min Soo Kim South Korea

Shashikant Patel India

Haley L. Bennett Australia

Wade H. Aaron United States

Sibylle Liebmann Germany

Rong Chu United States

Shaoyi Li

184 ×0.6

ONCOL

277 ×0.9

29 ×0.1

EPIDE

35 ×0.7

27 ×0.6

PRM

Citations per year, relative to Shaoyi Li Shaoyi Li (= 1×) peers Rong Chu

Countries citing papers authored by Shaoyi Li

Since Specialization

Citations

This map shows the geographic impact of Shaoyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoyi Li more than expected).

Fields of papers citing papers by Shaoyi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoyi Li. The network helps show where Shaoyi Li may publish in the future.

Co-authorship network of co-authors of Shaoyi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoyi Li. A scholar is included among the top collaborators of Shaoyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoyi Li. Shaoyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Li, Dongjun, et al.. (2024). Creation of signatures and identification of molecular subtypes of glioblastoma based on disulfidptosis-related genes for predicting patient prognosis and immunological activity. Asian Journal of Surgery. 47(8). 3464–3477. 2 indexed citations

Li, Chun, et al.. (2023). A controlled lumbar puncture procedure improves the safety of lumbar puncture. Frontiers in Neuroscience. 17. 1304150–1304150. 1 indexed citations

Liu, Zhaoyang, et al.. (2023). A study on pharmaceutical text relationship extraction based on heterogeneous graph neural networks. Mathematical Biosciences & Engineering. 21(1). 1489–1507.

Bal, Susan, Myo Htut, Omar Nadeem, et al.. (2023). BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 Study. Blood. 142(Supplement 1). 219–219. 32 indexed citations

Li, Han, et al.. (2021). Improvements in Nerve Dissection Surgery Methodology for Spasmodic Torticollis Treatment. World Neurosurgery. 156. 33–42.

Michot, Jean‐Marie, Julio C. Chávez, Cecilia Carpio, et al.. (2021). Clinical Activity of CC-99282, a Novel, Oral Small Molecule Cereblon E3 Ligase Modulator (CELMoD) Agent, in Patients (Pts) with Relapsed or Refractory Non-Hodgkin Lymphoma (R/R NHL) - First Results from a Phase 1, Open-Label Study. Blood. 138(Supplement 1). 3574–3574. 13 indexed citations

Zhao, Xuyang, Ya-Juan Zhao, Xueyan Liu, et al.. (2020). Quantitative Serum Proteomic Study Reveals that Fibrinogen-Related Proteins May Participate in the Pathophysiological Process of Simple Febrile Convulsion. Journal of the American Society for Mass Spectrometry. 31(3). 666–674. 1 indexed citations

Li, Chun, et al.. (2019). Pre-Operative Interictal Discharge Patterns and Magnetic Resonance Imaging Findings Affect Prognosis of Temporal Lobe Epilepsy Surgery. European Neurology. 81(3-4). 152–162. 3 indexed citations

Münster, Pamela N., Monica Mita, Amit Mahipal, et al.. (2019). <p>First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy</p>. Cancer Management and Research. Volume 11. 10463–10476. 67 indexed citations

10.

Liu, Yongqing, Shirong Lai, Ke Wei, et al.. (2017). CDYL suppresses epileptogenesis in mice through repression of axonal Nav1.6 sodium channel expression. Nature Communications. 8(1). 355–355. 43 indexed citations

11.

Li, Shaoyi, Wenchang Guo, Yun Gao, & Yunhui Liu. (2014). Ginsenoside Rh2 inhibits growth of glioblastoma multiforme through mTor. Tumor Biology. 36(4). 2607–2612. 21 indexed citations

12.

Li, Shaoyi, et al.. (2014). EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumor Biology. 35(6). 5593–5598. 55 indexed citations

13.

Pawel, Joachim von, Robert M. Jotte, David R. Spigel, et al.. (2014). Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology. 32(35). 4012–4019. 232 indexed citations

14.

Gajjar, Amar, Sridharan Gururangan, Ibrahim Qaddoumi, et al.. (2013). A prospective phase II study to determine the efficacy of GDC 0449 (vismodegib) in adults with recurrent medulloblastoma (MB): A Pediatric Brain Tumor Consortium study (PBTC 25B).. Journal of Clinical Oncology. 31(15_suppl). 2035–2035. 11 indexed citations

15.

Weiner, Michael W., Carl Sadowsky, Judith Saxton, et al.. (2011). Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease. Alzheimer s & Dementia. 7(4). 425–435. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact